Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MCLA-145 by Merus for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Negative...
MCLA-145 by Merus for Laryngeal Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Laryngeal Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Urethral Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Urethral Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Oral Cavity (Mouth) Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Oral Cavity (Mouth) Cancer. According to GlobalData,...
MCLA-145 by Merus for Hypopharyngeal Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Hypopharyngeal Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...
MCLA-145 by Merus for Transitional Cell Cancer (Urothelial Cell Cancer): Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Transitional Cell Cancer (Urothelial Cell Cancer). According...
MCLA-145 by Merus for Oropharyngeal Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Oropharyngeal Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Unspecified B-Cell Lymphomas: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Unspecified B-Cell Lymphomas. According to GlobalData, Phase...
MCLA-145 by Merus for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC)....
MCLA-145 by Merus for Bladder Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Bladder Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Non-Small Cell Lung Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
MCLA-145 by Merus for Glioblastoma Multiforme (GBM): Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...
MCLA-145 by Merus for Anal Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Anal Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Solid Tumor: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
MCLA-145 by Merus for Sarcomas: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Sarcomas. According to GlobalData, Phase I drugs...
MCLA-145 by Merus for Gastric Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Pancreatic Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Cervical Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Colorectal Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...